Concepedia

Publication | Open Access

Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer

DOIFull Paper Access

38

Citations

46

References

2016

Year

Mekhail Anwar, Vivian Weinberg, Zachary Seymour, I‐Chow Hsu, Mack Roach, A. Gottschalk
Radiation Oncology

Abstract

SBRT boost is well-tolerated for intermediate and high-risk prostate cancer patients with good biochemical outcomes and low toxicity.

References

YearCitations

Page 1